Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma Two abstracts featuring new Phase 2 data highlight the potential of CAR ...
Nexperia's China unit is expected to be capable of making deliveries to clients on the back of the domestic semiconductor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback